UK Judge Won't Invalidate Alcon's Glaucoma Treatment Patent
A United Kingdom judge on Friday upheld the validity of a glaucoma treatment patent owned by Novartis AG spinoff Alcon, which had been challenged by generic-drug companies....To view the full article, register now.
Already a subscriber? Click here to view full article